New regulations for food recall and food imports will go into effect in July.
The first of many regulations established under the new Food Safety Modernization Act were introduced last week, according to FDA reports. Both rules will come into effect on July 3.
First, a new regulation will allow FDA to detain any food product it believes is insanitary or unsafe to the general public. The agency will be able to detain a product for up to 30 days while deciding on further action (seizure, federal injunction against distribution, etc.). Previously, FDA needed sufficient evidence to characterize a product as contaminated or mislabeled in a way that posed a serious health risk to humans or animals. FDA would have to work with state agencies to embargo products before federal action could be initiated.
“This authority strengthens significantly the FDA’s ability to keep potentially harmful food from reaching U.S. consumers,” said FDA deputy commissioner for foods Michael Taylor. “It is a prime example of how the new food safety law allows FDA to build prevention into our food safety system.”
The second regulation relates to U.S. food imports. If a party imports a food product to the United States, that party will be required to disclose any previous refusals of the product by other countries. The regulation allows for FDA to make better informed decisions on imported food risks, said Taylor.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.